Long-term follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-risk Neuroblastoma: Children’s Oncology Group Study ANBL0032

PURPOSE: Previously our randomized Phase III trial demonstrated that immunotherapy including dinutuximab, a chimeric anti-GD2 monoclonal antibody, granulocyte macrophage-colony stimulating factor (GM-CSF), and interleukin-2 (IL2) improved survival for children with high-risk neuroblastoma that had r...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cancer Res
Main Authors: Yu, Alice L., Gilman, Andrew L., Ozkaynak, M. Fevzi, Naranjo, Arlene, Diccianni, Mitchell B., Gan, Jacek, Hank, Jacquelyn A., Batova, Ayse, London, Wendy B., Tenney, Sheena C., Smith, Malcolm, Shulkin, Barry L., Parisi, Marguerite, Matthay, Katherine K., Cohn, Susan L., Maris, John M., Bagatell, Rochelle, Park, Julie R., Sondel, Paul M.
Format: Artigo
Sprog:Inglês
Udgivet: 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046731/
https://ncbi.nlm.nih.gov/pubmed/33504555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-3909
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker